News
Recent news and updates from GlycaNova.
Latest news from the clinical trial
First patient dosed in clinical trial of LentinexHP in late-stage colorectal cancer Pioneering placebo-controlled trial of a novel beta-glucan dietary supplement administered alongside chemotherapy GlycaNova AS, the Norwegian biotechnology company focused on...